Mixed News on Tough-to-Treat Lung Cancer (HealthDay)
HealthDay – TUESDAY, Jan. 10 (HealthDay News) — Dutch researchers report
disappointing results from an early clinical trial of the drug Nexavar
(sorafenib) in fighting a tough-to-treat form of lung cancer.